Prokarium secures £4.6m Wellcome funding for Entervax
- Posted on 9 October, 2019
Prokarium has announced an investment of £4.59 million from Wellcome to fund two clinical trials of its lead programme, Entervax.
Follow this link for further information
http://www.pharmatimes.com/news/prokarium_secures_4.6m_wellcome_funding_for_entervax_1312196
Share this article:
People also read
New Government report
UK Government report published this week entitled “Engineering Biology: Opportunities for the UK Economy and National Goals”, is an important document...
SynbiCITE Showcase 2022
The aim of the 1-Day SynbiTECH Showcase was to reflect important issues and changes in the field of synthetic biology/engineering biology. As with the...
Measurement for Recovery
Measurement for RecoveryNew programme to help boost competitiveness and resilience of UK industry, led by the National Physical Laboratory (NPL)NPL is...